Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Decarli

Showing results (471-480 of 544) with videos related to

Pageof 55
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 16, 2022
MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortiumPauline Maillard, Laura J Hillmer, Hanzhang Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2014
Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonanceMarina Boccardi, Martina Bocchetta, Liana G Apostolova, et al.
Brain : a Journal of Neurology|May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Science Translational Medicine|January 21, 2021
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomographyJustin S Sanchez, J Alex Becker, Heidi I L Jacobs, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 6, 2022
Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kitsPauline Maillard, Hanzhang Lu, Konstantinos Arfanakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 1, 2019
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patientsHyemin Jang, Hee Jin Kim, Seongbeom Park, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2024
Implementation and validation of face de-identification (de-facing) in ADNI4Christopher G Schwarz, Mark Choe, Stephanie Rossi, et al.
Annals of Neurology|November 21, 2020
Diagnostic Accuracy of Amyloid versus <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed DementiaOrit H Lesman-Segev, Renaud La Joie, Leonardo Iaccarino, et al.
Neurology|February 3, 2019
Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysisYusuke Yakushiji, Duncan Wilson, Gareth Ambler, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Pageof 55

Showing results (471-480 of 544) with videos related to

Sort By:
Pageof 55
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 16, 2022
MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortiumPauline Maillard, Laura J Hillmer, Hanzhang Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2014
Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonanceMarina Boccardi, Martina Bocchetta, Liana G Apostolova, et al.
Brain : a Journal of Neurology|May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Science Translational Medicine|January 21, 2021
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomographyJustin S Sanchez, J Alex Becker, Heidi I L Jacobs, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 6, 2022
Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kitsPauline Maillard, Hanzhang Lu, Konstantinos Arfanakis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 1, 2019
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patientsHyemin Jang, Hee Jin Kim, Seongbeom Park, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2024
Implementation and validation of face de-identification (de-facing) in ADNI4Christopher G Schwarz, Mark Choe, Stephanie Rossi, et al.
Annals of Neurology|November 21, 2020
Diagnostic Accuracy of Amyloid versus <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed DementiaOrit H Lesman-Segev, Renaud La Joie, Leonardo Iaccarino, et al.
Neurology|February 3, 2019
Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysisYusuke Yakushiji, Duncan Wilson, Gareth Ambler, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Pageof 55